RecruitingNot ApplicableNCT05789901

The MARVIN Chatbots to Provide Information for Different Health Conditions

A Master Research Protocol to Adapt and Evaluate an Artificial Intelligence Based Conversational Agent to Provide Information for Different Health Conditions: the MARVIN Chatbots


Sponsor

McGill University Health Centre/Research Institute of the McGill University Health Centre

Enrollment

400 participants

Start Date

Mar 1, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This research is a continuation of a usability study with the MARVIN chatbot. The investigators aim to adapt the MARVIN chatbot to open it to other health domains (e.g. breast cancer) and populations (e.g. pharmacists). Therefore, this protocol constitutes a master research protocol that will englobe different research projects with individual chatbots. The investigators adopt an adaptive platform trial design, which will allow flexibility in handling multiple interventions adapted to different populations while retaining the characteristics of a platform trial design allowing early withdrawal of ineffective trial arms based on interim data (implementation outcomes) and introduction of new trial arms.


Eligibility

Min Age: 14 Years

Plain Language Summary

Simplified for easier understanding

This study is evaluating chatbots (automated conversational tools) as a way to provide health information to people with various medical conditions. The chatbots are delivered through an online platform and researchers want to know how useful, accurate, and user-friendly these tools are for patients seeking health information. **You may be eligible if...** - You are 14 years or older - You are fluent in English and/or French - You have access to a smartphone, tablet, or computer with internet - You are able to understand and consent to study participation - For some parts of the study: you are willing to use a Facebook Messenger-based chatbot and have or create a Facebook account **You may NOT be eligible if...** - You do not meet the above requirements - Your doctor believes you are not appropriate for participating in a study involving a chatbot (e.g., due to cognitive difficulties) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERMARVIN

Chatbot on Meta (Facebook) Messenger for HIV Patients

OTHERMARVIN-Pharma

Chatbot on Meta (Facebook) Messenger for community pharmacists

OTHERMARVINA

Chatbot on Meta (Facebook) Messenger for breast cancer patients

OTHERMARVIN-CHAMP

CHatbot to Assist the Management of Pediatric patients with infectious conditions (CHAMP)


Locations(2)

Centre hospitalier de l'Université de Montréal (CHUM)

Montreal, Quebec, Canada

McGill University Health Centre (MUHC)

Montreal, Quebec, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05789901


Related Trials